Type 1 diabetes in NOD mice unaffected by mast cell deficiency

Diabetes

Volumn 63, Issue 11, 2014, Pages 3827-3834

  Gutierrez, Dario A ^a   Fu, Wenxian ^b   Schonefeldt, Susann ^c,d   Feyerabend, Thorsten B ^a   Ortiz Lopez, Adriana ^b   Lampi, Yulia ^c,d   Liston, Adrian ^c,d   Mathis, Diane ^b   Rodewald, Hans Reimer ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CARBOXYPEPTIDASE A; CPA3 PROTEIN, MOUSE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CELL POLARITY; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; IMMUNE RESPONSE; IMMUNOREGULATION; INCIDENCE; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPH NODE CELL; MALE; MAST CELL; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; TH1 CELL; TH2 CELL; ANIMAL; AUTOIMMUNITY; CYTOLOGY; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; AUTOIMMUNITY; CARBOXYPEPTIDASES A; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; FEMALE; MALE; MAST CELLS; MICE; MICE, INBRED NOD;

EID: 84908611557     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0372     Document Type: Article

References (58)

1. Grimbaldeston MA, Metz M, Yu M, Tsai M, Galli SJ. Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses. Curr Opin Immunol 2006;18:751-760
2. Ludgate M, Baker G. Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease. Clin Exp Immunol 2002;127:193-198
3. Nelson KC, Zhao M, Schroeder PR, et al. Role of different pathways of the complement cascade in experimental bullous pemphigoid. J Clin Invest 2006; 116:2892-2900
4. Levi-Schaffer F, Klapholz L, Kupietzky A, Weinrauch L, Shalit M, Okon E. Increased numbers of mast cells in pemphigus vulgaris skin lesions. A histochemical study. Acta Derm Venereol 1991;71:269-271
5. Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002;297:1689-1692
6. Secor VH, Secor WE, Gutekunst CA, Brown MA. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med 2000;191:813-822
7. Akimoto S, Ishikawa O, Igarashi Y, Kurosawa M, Miyachi Y. Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation. Br J Dermatol 1998;138:399-406
8. Shiota N, Kakizoe E, Shimoura K, Tanaka T, Okunishi H. Effect of mast cell chymase inhibitor on the development of scleroderma in tight-skin mice. Br J Pharmacol 2005;145:424-431
9. Seeldrayers PA, Yasui D, Weiner HL, Johnson D. Treatment of experimental allergic neuritis with nedocromil sodium. J Neuroimmunol 1989;25:221-226
10. Geoffrey R, Jia S, Kwitek AE, et al. Evidence of a functional role for mast cells in the development of type 1 diabetes mellitus in the BioBreeding rat. J Immunol 2006;177:7275-7286
11. Hübner MP, Larson D, Torrero MN, et al. Anti-Fc'RI antibody injections activate basophils and mast cells and delay Type 1 diabetes onset in NOD mice. Clin Immunol 2011;141:205-217
12. Jones SE, Gilbert RE, Kelly DJ. Tranilast reduces mesenteric vascular collagen deposition and chymase-positive mast cells in experimental diabetes. J Diabetes Complications 2004;18:309-315
13. Hessner MJ, Wang X, Meyer L, et al. Involvement of eotaxin, eosinophils, and pancreatic predisposition in development of type 1 diabetes mellitus in the BioBreeding rat. J Immunol 2004;173:6993-7002
14. Sayed BA, Christy A, Quirion MR, Brown MA. The master switch: the role of mast cells in autoimmunity and tolerance. Annu Rev Immunol 2008;26:705-739
15. Benoist C, Mathis D. Mast cells in autoimmune disease. Nature 2002;420: 875-878
16. Feyerabend TB, Weiser A, Tietz A, et al. Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity. Immunity 2011;35:832-844
17. Rodewald HR, Feyerabend TB. Widespread immunological functions of mast cells: fact or fiction? Immunity 2012;37:13-24
18. Reber LL, Marichal T, Galli SJ. New models for analyzing mast cell functions in vivo. Trends Immunol 2012;33:613-625
19. Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am 2010;39:481-497
20. Kukreja A, Maclaren NK. Autoimmunity and diabetes. J Clin Endocrinol Metab 1999;84:4371-4378
21. Wicker LS, Todd JA, Peterson LB. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 1995;13:179-200
22. Anderson MS, Bluestone JA. The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 2005;23:447-485
23. Fox CC, Jewell SD, Whitacre CC. Rat peritoneal mast cells present antigen to a PPD-specific T cell line. Cell Immunol 1994;158:253-264
24. Frandji P, Oskéritzian C, Cacaraci F, et al. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J Immunol 1993;151:6318-6328
25. Stelekati E, Bahri R, D'Orlando O, et al. Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. Immunity 2009;31:665-676
26. Wang HW, Tedla N, Lloyd AR, Wakefield D, McNeil PH. Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J Clin Invest 1998;102:1617-1626
27. McLachlan JB, Hart JP, Pizzo SV, et al. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat Immunol 2003;4:1199-1205
28. Jawdat DM, Albert EJ, Rowden G, Haidl ID, Marshall JS. IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J Immunol 2004;173: 5275-5282
29. Suto H, Nakae S, Kakurai M, Sedgwick JD, Tsai M, Galli SJ. Mast cellassociated TNF promotes dendritic cell migration. J Immunol 2006;176:4102-4112
30. de Vries VC, Pino-Lagos K, Nowak EC, Bennett KA, Oliva C, Noelle RJ. Mast cells condition dendritic cells to mediate allograft tolerance. Immunity 2011;35: 550-561
31. Jawdat DM, Rowden G, Marshall JS. Mast cells have a pivotal role in TNFindependent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan. J Immunol 2006;177:1755-1762
32. Jutel M, Watanabe T, Klunker S, et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 2001; 413:420-425
33. Jutel M, Klunker S, Akdis M, et al. Histamine upregulates Th1 and downregulates Th2 responses due to different patterns of surface histamine 1 and 2 receptor expression. Int Arch Allergy Immunol 2001;124:190-192
34. Caron G, Delneste Y, Roelandts E, et al. Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J Immunol 2001;167: 3682-3686
35. Kitawaki T, Kadowaki N, Sugimoto N, et al. IgE-activated mast cells in combination with pro-inflammatory factors induce Th2-promoting dendritic cells. Int Immunol 2006;18:1789-1799
36. Shi MA, Shi GP. Different roles of mast cells in obesity and diabetes: lessons from experimental animals and humans. Front Immunol 2012;3:7
37. Lyon MF, Glenister PH. A new allele sash (Wsh) at the W-locus and a spontaneous recessive lethal in mice. Genet Res 1982;39:315-322
38. Leiter EH. The NOD mouse: a model for insulin-dependent diabetes mellitus. Curr Protoc Immunol 2001;15.9:Unit 15.9
39. Rodewald HR, Ogawa M, Haller C, Waskow C, DiSanto JP. Pro-thymocyte expansion by c-kit and the common cytokine receptor gamma chain is essential for repertoire formation. Immunity 1997;6:265-272
40. Antsiferova M, Martin C, Huber M, et al. Mast cells are dispensable for normal and activin-promoted wound healing and skin carcinogenesis. J Immunol 2013;191:6147-6155
41. Gomez-Pinilla PJ, Farro G, Di Giovangiulio M, et al. Mast cells play no role in the pathogenesis of postoperative ileus induced by intestinal manipulation. PLoS ONE 2014;9:e85304
42. Duttlinger R, Manova K, Berrozpe G, et al. The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melanogenesis in Wsh and Ph mutant mice. Proc Natl Acad Sci USA 1995;92:3754-3758
43. Nigrovic PA, Gray DH, Jones T, et al. Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. Am J Pathol 2008;173:1693-1701
44. Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010;464:1293-1300
45. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004; 22:745-763
46. Brown MA, Sayed BA, Christy A. Mast cells and the adaptive immune response. J Clin Immunol 2008;28:671-676
47. Galli SJ, Grimbaldeston M, Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 2008;8:478-486
48. Oka T, Kalesnikoff J, Starkl P, Tsai M, Galli SJ. Evidence questioning cromolyn's effectiveness and selectivity as a 'mast cell stabilizer' in mice. Lab Invest 2012;92:1472-1482
49. Feng ZC, Li J, Turco BA, Riopel M, Yee SP, Wang R. Critical role of c-Kit in beta cell function: increased insulin secretion and protection against diabetes in a mouse model. Diabetologia 2012;55:2214-2225
50. Dudeck A, Dudeck J, Scholten J, et al. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 2011;34: 973-984
51. Lilla JN, Chen CC, Mukai K, et al. Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl mice. Blood 2011;118:6930-6938
52. Hatfield J, Quirion M, Rao K, Brown M. NODckitW/Wv mast cell deficient mice fail to develop type 1 diabetes (Abstract). J Immunol 2010;184:135-139
53. Katz HR, Austen KF. Mast cell deficiency, a game of kit and mouse. Immunity 2011;35:668-670
54. Hübner MP, Shi Y, Torrero MN, et al. Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-b. J Immunol 2012;188:559-568
55. Metz M, Piliponsky AM, Chen CC, et al. Mast cells can enhance resistance to snake and honeybee venoms. Science 2006;313:526-530
56. Schneider LA, Schlenner SM, Feyerabend TB, Wunderlin M, Rodewald HR. Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin. J Exp Med 2007;204:2629-2639
57. Marichal T, Starkl P, Reber LL, et al. A beneficial role for immunoglobulin E in host defense against honeybee venom. Immunity 2013;39:963-975
58. Palm NW, Rosenstein RK, Yu S, Schenten DD, Florsheim E, Medzhitov R. Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity. Immunity 2013; 39:976-985